COMMUNIQUÉS West-GlobeNewswire

Number of voting rights as of September 30. 2019

03/10/2019 - 17:45

Nicox SA Société anonyme with a registered capital of € 29,914,920 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On October 3, 2019, MONTHLY PUBLICATION OF THE [...]

Nombre de droits de vote au 30 septembre 2019

03/10/2019 - 17:45

Nicox SA Société anonyme au capital de 29 914 920 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 3 octobre 2019, PUBLICATION MENSUELLE DU NOMBRE D’ [...]

Spineway : Report on the October 3, 2019 General Shareholders’ Meeting

03/10/2019 - 17:45

Report on the October 3, 2019 General Shareholders’ Meeting The Spineway Ordinary and Extraordinary Shareholders' Meeting met, on second notice after adjournment, on October 3, 2019 at 11:00 am at the company's [...]

SPINEWAY : Compte-rendu de l’Assemblée Générale du 3 octobre 2019

03/10/2019 - 17:45

Compte-rendu de l’Assemblée Générale du 3 octobre 2019 L'Assemblée Générale Ordinaire et Extraordinaire des actionnaires de Spineway s'est réunie ce 3 octobre 2019 à 11h00 au siège social de la société, sur deuxième [...]

Tauriga Sciences, Inc. to Showcase its Tauri-Gum Product Line as an Approved Exhibitor at Kosherfest 2019 on November 12th-13th

03/10/2019 - 17:29

Venue: The Meadowlands Exposition Center / Secaucus, New Jersey New York, NY, Oct. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating [...]

SHP Honors 111 Amedisys Care Centers with SHPBest Awards

03/10/2019 - 16:53

BATON ROUGE, La., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Strategic Healthcare Programs (SHP) recently honored 111 Amedisys, Inc. (NASDAQ:AMED) care centers with SHP Best Awards, recognizing agencies with consistently high- [...]

Cidara Therapeutics to Present New Clinical and Preclinical Data at Two Upcoming Medical Conferences

03/10/2019 - 16:22

SAN DIEGO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it will present three [...]

HempAmericana Enters Booming $71M Smokable Hemp Flower Market with November Branded Product Launch

03/10/2019 - 16:22

NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”), an emerging company in the CBD products market, is excited to announce the Company’s [...]

Innovation Pharmaceuticals Clinical Trial of Oral Brilacidin in Ulcerative Colitis Program Expected to Commence in December; Top-Line Data in Q1 2020

03/10/2019 - 15:30

BEVERLY, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders that management is finalizing [...]

Autolus Announces Data Presentation at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting

03/10/2019 - 15:08

Poster presentation will highlight preclinical data regarding feasibility, safety, and efficacy of AUTO6NG, a next generation programmed T cell product candidate for pediatric neuroblastoma LONDON, Oct. 03, 2019 (GLOBE [...]

Nemaura Medical Provides Update Regarding Commercial Launch of SugarBEAT® and First Patient User Experiences as Presented at EASD Symposia 2019 in Barcelona

03/10/2019 - 15:00

Loughborough, England, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive, affordable and [...]

Cerner and i2i Population Health Collaborate to Better Serve Medicaid Population

03/10/2019 - 15:00

Companies Aim to Improve Health Outcomes and Lower Costs for Underserved Communities KANSAS CITY, Mo., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN), a global health platform and innovation company [...]

Thesecondopinion Celebrates 50 Years of Empowering the Cancer Community

03/10/2019 - 15:00

More than 10,000 patients have benefitted from a free second opinion about their disease and treatment options Of note during Breast Cancer Awareness Month: 35 percent were breast cancer patients SAN FRANCISCO, Oct. 03 [...]

Obalon Announces Repayment of All Long-Term Debt and Regaining of Compliance with NASDAQ Listing Requirement

03/10/2019 - 15:00

SAN DIEGO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a San Diego-based company focused on commercializing the Obalon Balloon System, the first and only FDA-approved swallowable, gas- [...]

Golden Leaf Holdings Ltd. Announces Termination of Employment of President of Medical Marijuana Group Consulting Ltd. and Medical Marihuana Group Corporation

03/10/2019 - 14:45

TORONTO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) (“Golden Leaf” of the “Company”), a pioneering cannabis company with cultivation, production and retail operations built [...]

Marrone Bio Innovations to Attend the MicroCap Rodeo Investment Conference in Austin

03/10/2019 - 14:31

DAVIS, Calif., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, today announced that management has been [...]

PDS Biotechnology Corp. Announces Clinical Collaboration with Merck

03/10/2019 - 14:30

PDS0101- KEYTRUDA® (pembrolizumab) Combination to be Evaluated in First Line Treatment of Metastatic Head and Neck Cancer BERKELEY HEIGHTS, N.J., Oct. 03, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS [...]

American Cannabis Company, Inc. Strengthens Team By Adding New VP of Sales & Marketing

03/10/2019 - 14:30

DENVER, CO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business cannabis and hemp consulting solutions provider, is pleased to [...]

Tetra Bio-Pharma Provides Regulatory Update for Its CAUMZ(TM) Kit

03/10/2019 - 14:30

U.S. Food and Drug Administration (FDA) allows evaluation of CAUMZ Kit as a combination drug/device product, providing clarity on regulatory approval pathway This is a first step in the regulatory strategy to bring [...]